Cinolazepam
Ọdịdị
Clinical data | |
---|---|
Trade names | Gerodorm |
AHFS/Drugs.com | cinolazepam |
Routes of administration |
Oral |
ATC code | Page Templeeti:Plainlist/styles.css has no content.
|
Ọnọdụ iwu | |
Ọnọdụ iwu |
|
Ihe omuma pharmacokinetic | |
Bioavailability | 90-100% |
Metabolism | Ọrịa imeju |
<span class="nowrap">Ọkara ndụ</span> e wepụrụ | awa 3.8[1] |
Mgbapụta | Akụrụ |
Ihe ndị na-eme ka a mata ya | |
Aha IUPAC
| |
Nọmba CAS | |
PubChem <abbr title="<nowiki>Compound ID</nowiki>">CID | |
Ụlọ Akụ̀ Ọgwụ | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI |
|
ChEMBL | |
Ihe omuma kemịkal na nke anụ ahụ | |
Nhazi | C18H13ClFN3O2 |
Ọkpụkpụ nke ọkpụkpụ | 357.8 g·mol-1 |
Ihe nlereanya 3D (JSmol) | |
Chirality | Ngwakọta agbụrụ |
Mmetụta ihere
| |
InChI
| |
Page Templeeti:Nobold/styles.css has no content. NY (gịnị bụ nke a? (Nkwupụta) |
Cinolazepam[2] (nke a na-ere n'okpuru aha Gerodorm) bụ ọgwụ nke bụ benzodiazepine.[3] Ọ nwere ihe na-eme ka nchegbu kwụsị, ihe na-egbochi nkụchi, ihe na'ime ka ọ dị jụụ na ihe na-ehi ụra. N'ihi ikike ya ahazi na ụdị nke ụwa na ụdị ke amụta site na iji Tinye na Enyi siri ike, a na-eji ya eme ihe dị ka ọgwụ na-eme ka mmadụ kwụsị.
E nyere ya ikike n'afọ 1978 ma malite iji ya mee ihe n'ụzọ ọgwụ na 1992.[4] A kwadoghị Cinolazepam maka ire ere na United States ma ọ bụ Canada.
Ntụaka
[dezie | dezie ebe o si]- ↑ "ZUSAMMENFASSUNG DER MERKMALE DES ARZNEIMITTELS" (Press release). (in Austrian German). Austria: G.L. Pharma GmbH. Bundesamt für Sicherheit im Gesundheitswesen. October 2018. Archived from the original on 2019-01-02. Retrieved 2019-01-02.
- ↑ US Patent 4388313 Novel 3-hydroxy-1,4-benzodiazepine-2-ones and process for the preparation thereof
- ↑ Lannacher Romania (1999). Gerodorm (ro). Produse Gerot inregistrate in Romania. Archived from the original on 11 October 2006. Retrieved on 17 August 2006.
- ↑ (2006) Analogue-based Drug Discovery (in en). John Wiley & Sons. ISBN 9783527607495.